Remus Pharmaceuticals Limited (NSE:REMUS)

Remus Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	66.7	72.3	47.2	30.38	11.49	8.31
Short-Term Investments	142.7	200.4	202.4	-	-	-
Cash & Short-Term Investments	209.4	272.7	249.6	30.38	11.49	8.31
Cash Growth	-54.47%	9.25%	721.54%	164.51%	38.30%	-30.68%
Accounts Receivable	1,477	1,080	1,153	48.48	29.15	36.04
Receivables	1,605	1,290	1,335	48.48	29.15	36.04
Inventory	1,055	515.6	431.1	2.87	15.89	11.51
Prepaid Expenses	-	3.2	0.4	0.49	0.07	-
Other Current Assets	261.3	131.9	107.7	31.22	20.34	19.15
Total Current Assets	3,131	2,214	2,123	113.44	76.94	75
Property, Plant & Equipment	90.5	68.3	48.6	25.13	3.09	3.92
Long-Term Investments	2,245	1,953	1,064	206.16	30.68	0.67
Goodwill	87.3	87.3	87.3	-	-	-
Other Intangible Assets	0.7	2.6	2.1	0.5	-	-
Long-Term Deferred Tax Assets	-	-	-	1.27	0.41	0.6
Other Long-Term Assets	127.6	1.2	5.9	0.12	47.49	30.31
Total Assets	5,682	4,326	3,331	346.61	158.6	110.5
Accounts Payable	1,250	712.9	937.1	35.31	46.73	51.59
Accrued Expenses	3.1	14.6	10.4	8.61	2.75	9.63
Short-Term Debt	-	171.2	83.4	6.38	-	-
Current Portion of Long-Term Debt	87.2	3.6	2.1	2.16	0.93	0.87
Current Portion of Leases	7.6	5.1	5.1	-	-	-
Current Income Taxes Payable	55.7	28.1	14.4	6.75	4.71	3.58
Other Current Liabilities	545.2	279.8	358.6	22.41	36.71	11.24
Total Current Liabilities	1,949	1,215	1,411	81.62	91.84	76.92
Long-Term Debt	54	33.3	30	70.89	0.99	1.92
Long-Term Leases	11.3	16.6	21.7	-	-	-
Pension & Post-Retirement Benefits	-	5.7	4.2	2.75	-	1.2
Long-Term Deferred Tax Liabilities	280.5	229	111.6	-	-	-
Other Long-Term Liabilities	7.3	1	0.4	-	-	-
Total Liabilities	2,302	1,501	1,579	155.26	92.82	80.04
Common Stock	117.8	58.9	14.7	10.85	10	0.1
Additional Paid-In Capital	-	504.3	504.7	41.65	-	-
Retained Earnings	-	571.9	337.1	138.86	55.78	30.36
Comprehensive Income & Other	2,952	1,424	720.4	-	-	-
Total Common Equity	3,070	2,559	1,577	191.36	65.78	30.46
Minority Interest	309.9	266.9	175.2	-	-	-
Shareholders' Equity	3,380	2,826	1,752	191.36	65.78	30.46
Total Liabilities & Equity	5,682	4,326	3,331	346.61	158.6	110.5
Total Debt	160.1	229.8	142.3	79.43	1.92	2.79
Net Cash (Debt)	49.3	42.9	107.3	-49.05	9.57	5.52
Net Cash Growth	-80.40%	-60.02%	-	-	73.48%	-34.24%
Net Cash Per Share	4.03	3.64	9.50	-6.00	1.20	0.69
Filing Date Shares Outstanding	9.55	11.66	11.78	8.68	8.68	8
Total Common Shares Outstanding	9.55	11.66	11.78	8.68	8.68	8
Working Capital	1,182	998.4	712.2	31.82	-14.9	-1.91
Book Value Per Share	321.55	219.47	133.82	22.05	7.58	3.81
Tangible Book Value	2,982	2,469	1,488	190.85	65.78	30.46
Tangible Book Value Per Share	312.33	211.76	126.23	21.99	7.58	3.81
Buildings	-	3.3	3.3	3.28	-	-
Machinery	-	69.7	35.8	31.07	7.89	7.18
Construction In Progress	-	-	0.1	0.22	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.